Plantar Fibromatosis
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) (NCT06151197) | Endo USA Inc., a Keenova Therapeutics Company | 2023-11-28 |
| Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis (NCT05254457) | Endo USA Inc., a Keenova Therapeutics Company | 2022-02-14 |
| Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (NCT05152173) | Endo USA Inc., a Keenova Therapeutics Company | 2021-11-29 |
Track Plantar Fibromatosis automatically
Every clearance here is in the API, with alerts when new ones post.